Green Alpha Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DIM
VFA
GI
MPWT
VCM
FFA
Green Alpha Advisors's EDIT Position: Q3 2026 in Review
Green Alpha Advisors reduced its Editas Medicine (EDIT) stake by 84% in Q3 2026, selling an estimated $386K and leaving 24,303 shares worth $62.5K. The position accounts for 0.04% of the portfolio, ranked #106.
Green Alpha Advisors first reported a position in EDIT in Q4 2020 and has held it in 24 quarters since. The position peaked at $4.02M in Q2 2022. 7 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Green Alpha Advisors held 24,303 shares of Editas Medicine worth $62.5K as of Q3 2026.
- Green Alpha Advisors sold 131,743 Editas Medicine shares in Q3 2026, an estimated $386K.
- Editas Medicine made up 0.04% of Green Alpha Advisors's portfolio in Q3 2026, its #106 holding.
- Green Alpha Advisors first reported a position in Editas Medicine in Q4 2020 and has held it in 24 quarters since.
- Green Alpha Advisors's Editas Medicine position peaked at $4.02M in Q2 2022.
- 7 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.